In the latest session, Alto Neuroscience Inc. (NYSE: ANRO) closed at $15.35 down -8.52% from its previous closing price of $16.78. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 208815 shares were traded. ANRO stock price reached its highest trading level at $16.67 during the session, while it also had its lowest trading level at $15.35.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Alto Neuroscience Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.22 and its Current Ratio is at 15.22.
On February 27, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $32.Stifel initiated its Buy rating on February 27, 2024, with a $32 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 06 ’24 when Alpha Wave Global, LP bought 600,000 shares for $16.00 per share. The transaction valued at 9,600,000 led to the insider holds 3,707,757 shares of the business.
Savitz Adam bought 17,000 shares of ANRO for $272,000 on Feb 06 ’24. The CHIEF MEDICAL OFFICER now owns 24,851 shares after completing the transaction at $16.00 per share. On Feb 06 ’24, another insider, Etkin Amit, who serves as the PRESIDENT AND CEO of the company, bought 3,125 shares for $16.00 each. As a result, the insider paid 50,000 and bolstered with 1,205,465 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANRO now has a Market Capitalization of 451.11M and an Enterprise Value of 378.55M.
Stock Price History:
Over the past 52 weeks, ANRO has reached a high of $24.00, while it has fallen to a 52-week low of $12.83. The 50-Day Moving Average of the stock is 15.66, while the 200-Day Moving Average is calculated to be 15.66.
Shares Statistics:
For the past three months, ANRO has traded an average of 353.00K shares per day and 364.64k over the past ten days. A total of 26.88M shares are outstanding, with a floating share count of 21.76M. Insiders hold about 19.05% of the company’s shares, while institutions hold 21.86% stake in the company. Shares short for ANRO as of Mar 15, 2024 were 1.93M with a Short Ratio of 5.46, compared to 772.87k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.17% and a Short% of Float of 9.11%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.41 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.83 and -$2.14 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is -$2.48, with 5 analysts recommending between -$2.19 and -$3.26.
